Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
6.64M
-
Shares change
-
-24.4K
-
Total reported value, excl. options
-
$160M
-
Value change
-
-$773K
-
Put/Call ratio
-
1.75
-
Number of buys
-
14
-
Number of sells
-
-15
-
Price
-
$24.08
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2016
45 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q3 2016.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.64M shares
of 95.5M outstanding shares and own 6.95% of the company stock.
Largest 10 shareholders include FMR LLC (3.53M shares), Cormorant Asset Management, LLC (498K shares), ORBIMED ADVISORS LLC (350K shares), Tekla Capital Management LLC (310K shares), LAZARD ASSET MANAGEMENT LLC (285K shares), FRANKLIN RESOURCES INC (244K shares), MILLENNIUM MANAGEMENT LLC (182K shares), PERCEPTIVE ADVISORS LLC (180K shares), Clough Capital Partners L P (153K shares), and Artal Group S.A. (150K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.